# CINVANTI

NDC: 47426-201
Generic name: aprepitant
Labeler / Manufacturer: Heron Therapeutics, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, EMULSION
Routes: INTRAVENOUS
Marketing started: 20180103

FDA application: NDA209296

## Active ingredients

- APREPITANT: 130 mg/18mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"47426-201"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=47426-201
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4c218d3a-a508-4abc-9ed8-a6e8e191d1b4